Author:
Varley Cara D.,Winthrop Kevin L.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria ATJ, et al. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia. Ann Rheum Dis. 2021;80(1):e10.
2. Vikse J, Jonsdottir K, Kvaloy JT, Wildhagen K, Omdal R. Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases. Rheumatol Int. 2019;39(6):1083–90.
3. Winthrop KL, Saag K, Cascino MD, Pei J, John A, Jahreis A, et al. Long-Term Safety of Rituximab in Rheumatoid Arthritis: Analysis From the SUNSTONE Registry. Arthritis care & research. 2018.
4. Gron KL, Arkema EV, Glintborg B, Mehnert F, Ostergaard M, Dreyer L, et al. Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden. Ann Rheum Dis. 2019;78(3):320–7.
5. Gron KL, Glintborg B, Norgaard M, Mehnert F, Ostergaard M, Dreyer L, et al. Overall infection risk in rheumatoid arthritis during treatment with abatacept, rituximab and tocilizumab; an observational cohort study. Rheumatology (Oxford, England). 2020;59(8):1949–56.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献